AND NOW RESULTS IN 4 DAYS, WAIT NO LONGER!
3 BBSafe® OPTIONS
What do we analyze?
Patau syndrome (trisomy chromosome 13)
Edwards’ syndrome (trisomy chromosome 18)
Down syndrome (trisomy chromosome 21)
Turner, Klinefelter, XYY and triple X syndrome (sex chromosome aneuploidies)
Fetal sex (optional)
Patau syndrome (trisomy chromosome 13)
Edwards’ syndrome (trisomy chromosome 18)
Down syndrome (trisomy chromosome 21)
Turner, Klinefelter, XYY and triple X syndrome (sex chromosome aneuploidies)
Fetal sex (optional)
Trisomies in chromosomes 9, 15, 16, and 22
Cri-du-chat syndrome (Sp)
1p36 deletion syndrome
Microdeletion 2q33.1 syndrome
Patau syndrome (trisomy chromosome 13)
Edwards’ syndrome (trisomy chromosome 18)
Down syndrome (trisomy chromosome 21)
Turner, Klinefelter, XYY and triple X syndrome (sex chromosome aneuploidies)
Fetal sex (optional)
Trisomies in chromosomes 9, 15, 16, and 22
Cri-du-chat syndrome (Sp)
1p36 deletion syndrome
Microdeletion 2q33.1 syndrome
Van der Woude syndrome 1q32-q41
DiGeorge 2 syndrome 10p14-p13
Jacobsen syndrome (11q deletion)
Microdeletion syndrome 16p12.2-p11.2
Autosomal trisomies on all chromosomes
It is the most reliable non-invasive prenatal test on the market that analyzes circulating free fetal DNA. No risk for the mother or the baby.
Through a simple maternal blood sample, BBSafe® detects the most frequent chromosomal abnormalities in pregnancy such as Patau Syndrome (trisomy 13), Edwards Syndrome (trisomy 18) and Down Syndrome (trisomy 21), among others.
Through an exhaustive analysis of this DNA we look for signs of specific chromosomal alterations. With this information we elaborate a personalized report indicating the risks that the future baby has of suffering the different anomalies.
In addition, with this test you will also be able to know the sex of the baby with great precision whenever you wish.
- Pregnancies from the 10th week of gestation.
- In twin pregnancies 12th week of gestation.
- Can be performed in cases of assisted reproduction, including IVF with gamete donation.
The results are reported as:
- LOW RISK or HIGH RISK of presenting the numerical chromosomal alterations studied.
- In case of a High Risk result, Cerba International offers the option of performing an invasive prenatal diagnostic test for confirmation at no additional cost.
- The identification of fetal sex has a high degree of accuracy. This is an optional test.
- The NON-valuable result rate of BBSafe® is 0.44%.
ACCURACY
Our industry-leading technology allows you to accurately determine the length of free DNA fragments, an essential skill in a variety of fields, from medical research to forensic genetics. This technology efficiently distinguishes between fetal and maternal DNA fragments, even in cases of low fetal fractions. This significantly reduces the need for invasive procedures, resulting in cost savings and a higher level of confidence in your results.
FETAL FRACTION QUANTIFICATION
Our advanced analysis algorithms not only quantify the fetal fraction accurately, but also incorporate other essential sequencing parameters. This means you can count on reliable results, even in situations where the fetal fraction is minimal. In approximately 99% of cases, we deliver complete reports without the need for repeat samples, streamlining your processes.
A RELIABLE PARTNER
With 75 years of industry experience behind us, we work in collaboration with Illumina, a world leader in DNA sequencing, ensuring that we are a trusted partner with a proven track record of excellence in the field.
QUALITY GUARANTEED IN SPAIN
Our services are performed entirely in our laboratory in Spain backed by ISO 15189 accreditation of a large majority of our laboratory techniques.
Join the genomic revolution with CERBA and discover the difference that massive bidirectional genome sequencing technology makes! Your genetic future is clearer than ever.
Accuracy
≥ 99,9% sensitivity and specificity
| TRISOMY 13 (Patau’s syndrome) |
TRISOMY 18 (Edwards’s syndrome) |
TRISOMY 21 (Down’s syndrome) |
SEXUAL CHROMOSOMES |
*CNV’s ≥ 7 Mb | |
|---|---|---|---|---|---|
| SENSITIVITY | 99,9 % | 99,9 % | 99,9 % | 99,9 % | 74,1 % |
| SPECIFICITY | 99,9 % | 99,9 % | 99,9 % | > 85 % | 99,8 % |
* Duplications / deletions (CNVs) of size greater than or equal to 7 Mb are detected.
BBSafe®
Process
Go to a Cerba center to have the test done.
The test can be performed from week 10 (from week 12 for twin pregnancies).Fetal DNA is found in maternal blood.
Fetal DNA is separated from maternal DNA and sequenced by next-generation techniques (NGS).We perform an exhaustive analysis of this fetal DNA.
Specific chromosomal alterations are detected in the fetal DNA.Download your results in 4 working days.
